An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program

Antonello Sica, Caterina Sagnelli, Alfonso Papa, Massimo Ciccozzi, Evangelista Sagnelli, Armando Calogero, Erika Martinelli and Beniamino Casale
Additional contact information
Antonello Sica: Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy
Caterina Sagnelli: Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy
Alfonso Papa: Pain Department, AORN Dei Colli V. Monaldi, 80131 Naples, Italy
Massimo Ciccozzi: Medical Statistics and Molecular Epidemiology, Campus Bio-Medico University, 00100 Rome, Italy
Evangelista Sagnelli: Department of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy
Armando Calogero: Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy
Erika Martinelli: Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, Italy
Beniamino Casale: Department of Pneumology and Tisiology, AORN Dei Colli - V. Monaldi, 80131 Naples, Italy

IJERPH, 2020, vol. 17, issue 6, 1-8

Abstract: Chronic lymphatic leukemia (CLL) is the most frequent type of leukemia in western countries and when association with del(11q) is correlated with a worse prognosis. We reported the clinical case of an 80-year-old patient with CLL related to del(11q) and a BMI of 16.4 kg/m 2 , who presented a voluminous mass in abdominal cavity (23 × 14 × 4 cm) which occupied the whole of the mesentery and the retroperitoneal space, treated with ibrutinib, adequate nutrition, and a program of physical activity. He showed a great improvement under ibrutinib therapy and took to artificial nourishment and adequate muscle rehabilitation until he recovered his autonomy. In August 2018, a 5-days-a-week training program was started: Physical activity for at least 20 min consisting of a fast walk in the open air three times a week and a moderate physical activity in the remaining two days of at least 20 consecutive minutes (cycling at a regular pace, carrying light weights). The exercise program included also aerobic, upper and lower limb resistance training, chore stability and stretches. The physical condition further improved and remained excellent throughout the follow-up period. In December 2018, his clinical condition was quite normal; a CT showed a great decrease of all lymphoadenomegaly, and FISH test did not show del(11q). He continued to cultivate his land, while still being treated with ibrutinib. The combination of the right therapy, adequate nutrition, and muscle rehabilitation is the best solution to improve the clinical condition of old cachectic CLL del(11q) patient.

Keywords: physical activity; elder age; CLL; del(11q); ibrutinib (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2020
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/17/6/1929/pdf (application/pdf)
https://www.mdpi.com/1660-4601/17/6/1929/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:17:y:2020:i:6:p:1929-:d:333013

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().